TMPRSS2 and prostate carcinoma: Companies like China Medical Technologies (http://www.chinameditech.com) and KREATECH (http://www.kreatech.com) have developed kits to detect the fusion of TMPRSS2 with an ETS family member, increasing the sensitivity of diagnosing prostate cancer (Perner et al., 2007).